Effect of Dexmedetomidine on Postoperative Plasma Neurofilament Light Chain in Elderly Patients Undergoing Thoracoscopic Surgery: A Prospective, Randomized Controlled Trial
Yue-ru Hou,Cheng-yun Xu,Ming-zi An,Zhen-ping Li,Hua-dong Ni,Tao Chen,Qing-he Zhou
DOI: https://doi.org/10.2147/cia.s422560
IF: 3.829
2023-09-15
Clinical Interventions in Aging
Abstract:Yue-ru Hou, 1, 2 Cheng-yun Xu, 1, 2 Ming-zi An, 1, 2 Zhen-ping Li, 2 Hua-dong Ni, 2 Tao Chen, 3 Qing-he Zhou 2 1 Anesthesia Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Anesthesiology and Pain Medicine, the Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, People's Republic of China; 3 Department of Anesthesiology, Tongxiang First People's Hospital, Tongxiang, Zhejiang, People's Republic of China Correspondence: Tao Chen, Department of Anesthesiology, Tongxiang First People's Hospital, No. 1918, Xiaochang Road, Tongxiang, Zhejiang, 314599, People's Republic of China, Tel +8613967327686, Fax +86 0573 8802 5098, Email Qing-he Zhou, Department of Anesthesiology and Pain Medicine, the Affiliated Hospital of Jiaxing University, No. 1882, Ring 2nd South Road, Jiaxing, Zhejiang, 314000, People's Republic of China, Tel +8613732573379, Fax +86 0573 8999 7760, Email Purpose: Dexmedetomidine exerts a neuroprotective effect, however, the mechanism underlying this effect remains unclear. This study aimed to explore whether dexmedetomidine can reduce the increase in neurofilament light chain (NfL) protein concentration to play a neuroprotective role during thoracoscopic surgery. Patients and Methods: Patients aged ≥ 60 years undergoing general anesthesia for thoracoscopic surgery were randomly assigned to receive dexmedetomidine (group D) or not receive dexmedetomidine (group C). Patients in group D received a loading dose of dexmedetomidine 0.5 μg/kg before anesthesia induction and a continuous infusion at 0.5 μg·kg − 1 ·h − 1 until the end of the surgery. Dexmedetomidine was not administered in group C. The primary outcome was the NfL concentration on postoperative day 1. The concentrations of procalcitonin (PCT), serum amyloid A (SAA), and high-sensitivity C-reactive protein (hs-CRP) were detected preoperatively and on postoperative day 1. In addition, the numerical rating scale (NRS) and quality of recovery-40 (QoR-40) scores were evaluated. Results: A total of 38 patients in group D and 37 in group C were included in the analysis. No differences were observed between the groups in terms of the plasma concentration of NfL preoperatively and on postoperative day 1 (11.17 [8.86, 13.93] vs 13.15 [10.76, 15.56] pg/mL, P > 0.05; 16.70 [12.23, 21.15] vs 19.48 [15.25, 22.85] pg/mL, P > 0.05, respectively). However, the postoperative plasma NfL concentration was significantly higher than the preoperative value in both groups (both P < 0.001). The groups exhibited no differences in PCT, SAA, hs-CRP, NRS, and QoR-40 (all P > 0.05). Conclusion: Intraoperative administration of dexmedetomidine at a conventional dose does not appear to significantly reduce the increase in postoperative plasma NfL concentration in elderly patients undergoing thoracoscopic surgery. This finding suggests that the neuroprotective effect of dexmedetomidine at a conventional dose was not obvious during general anesthesia. Keywords: dexmedetomidine, thoracoscopic surgery, neurofilament light chain, general anesthesia At present, over 300 million surgical procedures are performed worldwide annually, and a large proportion of these cases involve the use of general anesthesia. General anesthesia and surgery have been demonstrated to be associated with central nervous system damage, 1 particularly in the form of postoperative cognitive impairment. 2,3 As previously reported, the incidence of postoperative delirium (POD) among surgical patients is approximately 36.8%, 4 and it is associated with increased rates of dementia and mortality, especially in elderly surgical patients. 4,5 The literature includes studies reporting the direct neurotoxic effects of general anesthetics and surgery. 1,6 In addition, a study by Laszlo Vutskits et al reported that anesthetics can trigger long-term morphological and functional alterations in the brain. 7 Dexmedetomidine, a potent and highly selective agonist of α 2 -adrenergic receptors, is routinely used as an adjunct to anesthesia. Previous studies have demonstrated that dexmedetomidine exerts a neuroprotective effect; 8–10 it has also been reported to inhibit neuroendocrine and inflammatory responses 11,12 and blunt stress response by reducing the levels of serum catecholamine, cortisol, and cytokine. 13 Recent experimental studies have also reported that dexmedetomidine exerts long-term effects on the brain, including neuroprotective activity against excitotoxic da -Abstract Truncated-
geriatrics & gerontology,gerontology